February 5, 2021

Maryland Department of Commerce: Vigene Bioscience...

Vigene Biosciences Plans Major Expansion in Montgomery County, Adding up to 245 New Jobs   Global leader in gene therapy […]
November 3, 2020

Vigene Strengthens Management Team with Another Ke...

Vigene Biosciences announces today another key executive addition. Audrey Chang, Ph.D. is appointed as the VP of QC and Analytical Services.
October 12, 2020

Vigene Strengthens Management Team Critical Execut...

Vigene Biosciences announces today an executive addition. Molly McGlaughlin is appointed as Chief Operation Officer.
October 9, 2020

Rznomics Announces Manufacturing Agreement with Vi...

Vigene has entered a contract manufacturing agreement with Rznomics Inc. for its leading pipeline product, RZ-001. RZ-001 is a gene therapy for advanced hepatocellular carcinoma (HCC).
August 31, 2020

Vigene Biosciences made the 2020 Inc. 5000 list of...

Vigene Biosciences made the 2020 Inc. 5000 list of the fastest-growing private companies in America!
July 22, 2020

Altimmune Announces Manufacturing Agreement with V...

Vigene entered an agreement with Altimmune to manufacture its single-dose intranasal vaccine candidate for COVID-19.
June 4, 2020

Vigene Biosciences Awarded Patent for improvements...

The modifications on AAV vector leads to 2-4 folds increase in production yield.
February 27, 2020

Vigene Biosciences Awarded Patent for improvements...

ROCKVILLE, Md. – February 24, 2020 – Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and […]
February 27, 2020

Vigene and ASC Therapeutics Announce Long-Term Str...

ROCKVILLE, Md. Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development for cell and gene […]
February 27, 2020

Vigene Biosciences Opens State-Of-The-Art Headquar...

ROCKVILLE, MD – January 29, 2020 – Vigene Biosciences, Inc. (Vigene), a pioneer in the viral gene delivery space, unveils […]